海外の治験の状況「%E8%84%B3%E5%8D%92%E4%B8%AD」での検索結果
529件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Recruiting
- A Study of Long-term Baricitinib (LY3009104) Therapy in Atopic Dermatitis
- Atopic Dermatitis
- Argentina, Australia, Austria, Canada, Czechia, Denmark, France, Germany, Hungary, India, Ireland, Israel, Italy, Japan, Korea, Republic of, Mexico, Poland, Russian Federation, Spain, Swaziland, Switzerland, Taiwan
- 2017-11-03
Recruiting
- Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis
- Atopic Dermatitis;Atopic Dermatitis Eczema;Eczema;Atopic Dermatitis and Related Conditions
- United States
- 2017-09-21
Recruiting
- Adenovirus-specific Cytotoxic T-lymphocytes for Refractory Adenovirus Infection
- Adenovirus;Primary Immune Deficiency Disorder
- United States
- 2017-08-25
Recruiting
- A Study of ATI-502 Topical Solution for the Treatment of Atopic Dermatitis
- Atopic Dermatitis
- United States
- 2018-06-25
Recruiting
- A Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of Adenovirus Serotype 26 Based Respiratory Syncytial Virus Pre-fusion (Ad26.RSV.Pre-F) Vaccine in RSV-Seronegative Toddlers 12 to 24 Months of Age
- Respiratory Syncytial Virus
- Australia, Brazil, Canada, Finland, Germany, New Zealand, Poland, Spain, Sweden, United Kingdom, United States
- 2018-06-20
Recruiting
- Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis
- Atopic Dermatitis
- United States
- 2018-06-13
Recruiting
- Vaccine Responses in Tralokinumab-Treated Atopic Dermatitis - ECZTRA 5 (ECZema TRAlokinumab Trial No. 5)
- Atopic Dermatitis;Atopic Dermatitis
- Canada, United States
- 2018-06-08
Recruiting
- Effect of Benralizumab in Atopic Dermatitis
- Dermatitis, Atopic;Dermatitis;Eczema;Skin Diseases;Skin Diseases, Genetic;Genetic Diseases, Inborn;Skin Diseases, Eczematous;Hypersensitivity;Hypersensitivity, Immediate;Immune System Diseases
- Canada
- 2018-06-08
Recruiting
- A Study of Baricitinib (LY3009104) in Participants With Moderate to Severe Atopic Dermatitis
- Atopic Dermatitis
- Canada, Puerto Rico, United States
- 2018-06-06
Recruiting
- Phase 2b Study to Evaluate the Efficacy and Safety of GBR 830 in Adults With Moderate to Severe Atopic Dermatitis
- Moderate to Severe Atopic Dermatitis;Moderate to Severe Atopic Dermatitis
- Canada, Czechia, Germany, Poland, United States
- 2018-05-31
